Literature DB >> 18560888

Incidence of hepatotropic viruses in biliary atresia.

Stefan Rauschenfels1, Miriam Krassmann, Ahmed N Al-Masri, Willem Verhagen, Johannes Leonhardt, Joachim F Kuebler, Claus Petersen.   

Abstract

Biliary atresia (BA) is the most frequent indication for paediatric liver transplantation. We tested the hypothesis of a viral aetiology of this disease by screening liver samples of a large number of BA patients for the common human hepatotropic viruses. Moreover, we correlated our findings to the expression of Mx protein, which has been shown to be significantly up-regulated during viral infections. Seventy-four liver biopsies (taken during Kasai portoenterostomy) were tested by polymerase chain reaction (PCR) for DNA viruses (herpes simplex virus [HSV], Epstein-Barr virus [EBV], varicella zoster virus [VZV], cytomegalovirus [CMV], adenovirus, parvovirus B19 and polyoma BK) and RNA viruses (enteroviruses, rotavirus and reovirus 3). Mx protein expression was assessed by immunohistochemistry. Virus DNA/RNA was found in less than half of the biopsies (8/74 CMV, 1/74 adenovirus; 21/64 reovirus, 1/64 enterovirus). A limited number presented with double infection. Patients that had detectable viral RNA/DNA in their liver biopsies were significantly older than virus-free patients (P = 0.037). The majority (54/59) of the liver biopsies showed expression of Mx proteins in hepatocytes, bile ducts and epithelium. Our data suggest that the known hepatotropic viruses do not play a major role in the aetiology and progression of BA. Their incidence appears to be, rather, a secondary phenomenon. Nonetheless, the inflammatory response in the livers of BA patients mimics that observed during viral infections.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18560888     DOI: 10.1007/s00431-008-0774-2

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  35 in total

1.  Intracellular staining of Mx proteins in cells from peripheral blood, bone marrow and skin.

Authors:  A N al-Masri; T Werfel; D Jakschies; P von Wussow
Journal:  Mol Pathol       Date:  1997-02

2.  The MxA protein levels in whole blood lysates of patients with various viral infections.

Authors:  V Chieux; D Hober; J Harvey; G Lion; D Lucidarme; G Forzy; M Duhamel; J Cousin; H Ducoulombier; P Wattré
Journal:  J Virol Methods       Date:  1998-02       Impact factor: 2.014

3.  Considerations of the pathogenesis of neonatal hepatitis, biliary atresia and choledochal cyst--the concept of infantile obstructive cholangiopathy.

Authors:  B H Landing
Journal:  Prog Pediatr Surg       Date:  1974

4.  Genetics, immunology, and biliary atresia: an opening or a diversion?

Authors:  R A Schreiber; R E Kleinman
Journal:  J Pediatr Gastroenterol Nutr       Date:  1993-02       Impact factor: 2.839

5.  Extrahepatic bile duct atresia and viral involvement.

Authors:  Rannveig Bremer Fjaer; Anne-Lise Bruu; Svein Arne Nordbø
Journal:  Pediatr Transplant       Date:  2005-02

6.  Expression of interferon-inducible Mx-proteins in patients with IgA nephropathy or Henoch-Schönlein purpura.

Authors:  J Floege; M Burg; A N Al Masri; H J Gröne; P von Wussow
Journal:  Am J Kidney Dis       Date:  1999-03       Impact factor: 8.860

7.  Lack of evidence for rotavirus by polymerase chain reaction/enzyme immunoassay of hepatobiliary samples from children with biliary atresia.

Authors:  L Bobo; C Ojeh; D Chiu; A Machado; P Colombani; K Schwarz
Journal:  Pediatr Res       Date:  1997-02       Impact factor: 3.756

Review 8.  Antiviral actions of interferons.

Authors:  C E Samuel
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

9.  Detection of reovirus RNA in hepatobiliary tissues from patients with extrahepatic biliary atresia and choledochal cysts.

Authors:  K L Tyler; R J Sokol; S M Oberhaus; M Le; F M Karrer; M R Narkewicz; R W Tyson; J R Murphy; R Low; W R Brown
Journal:  Hepatology       Date:  1998-06       Impact factor: 17.425

10.  Biliary atresia and cytomegalovirus infection: a DNA study.

Authors:  G P Jevon; J E Dimmick
Journal:  Pediatr Dev Pathol       Date:  1999 Jan-Feb
View more
  29 in total

1.  Cholangiocyte N-Ras protein mediates lipopolysaccharide-induced interleukin 6 secretion and proliferation.

Authors:  Steven P O'Hara; Patrick L Splinter; Christy E Trussoni; Gabriella B Gajdos; Pooja N Lineswala; Nicholas F LaRusso
Journal:  J Biol Chem       Date:  2011-07-13       Impact factor: 5.157

2.  Identification of a plant isoflavonoid that causes biliary atresia.

Authors:  Kristin Lorent; Weilong Gong; Kyung A Koo; Orith Waisbourd-Zinman; Sara Karjoo; Xiao Zhao; Ian Sealy; Ross N Kettleborough; Derek L Stemple; Peter A Windsor; Stephen J Whittaker; John R Porter; Rebecca G Wells; Michael Pack
Journal:  Sci Transl Med       Date:  2015-05-06       Impact factor: 17.956

Review 3.  Biliary atresia: cellular dynamics and immune dysregulation.

Authors:  Amy G Feldman; Cara L Mack
Journal:  Semin Pediatr Surg       Date:  2012-08       Impact factor: 2.754

Review 4.  Clues to the etiology of bile duct injury in biliary atresia.

Authors:  Cara L Mack; Amy G Feldman; Ronald J Sokol
Journal:  Semin Liver Dis       Date:  2013-02-08       Impact factor: 6.115

5.  Patients with biliary atresia have elevated direct/conjugated bilirubin levels shortly after birth.

Authors:  Sanjiv Harpavat; Milton J Finegold; Saul J Karpen
Journal:  Pediatrics       Date:  2011-11-21       Impact factor: 7.124

6.  Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells.

Authors:  Stephen M Brindley; Allison M Lanham; Frederick M Karrer; Rebecca M Tucker; Andrew P Fontenot; Cara L Mack
Journal:  Hepatology       Date:  2012-04       Impact factor: 17.425

Review 7.  Liver fibrosis in biliary atresia.

Authors:  Wen-Jun Shen; Gong Chen; Min Wang; Shan Zheng
Journal:  World J Pediatr       Date:  2018-11-21       Impact factor: 2.764

8.  Parvovirus B19 genotype specific amino acid substitution in NS1 reduces the protein's cytotoxicity in culture.

Authors:  Violetta Kivovich; Leona Gilbert; Matti Vuento; Stanley J Naides
Journal:  Int J Med Sci       Date:  2010-05-25       Impact factor: 3.738

9.  [Predictive parameters in children with biliary atresia].

Authors:  J Leonhardt; J F Kuebler; C Turowski; R von Wasielewski; E D Pfister; T Becker; B M Ure; C Petersen
Journal:  Chirurg       Date:  2009-07       Impact factor: 0.955

Review 10.  Biliary atresia.

Authors:  Giorgina Mieli-Vergani; Diego Vergani
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.